The Patent Finder

Molecular Partners AG

22 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Apr 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 18, 2026
    The maintenance fee for Capping Modules for Designed Ankyrin Repeat Proteins (US 10,322,190) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
  • 1 fee due Feb 6, 2027
    The maintenance fee for Binding Proteins Comprising at Least Two Repeat Domains Against HER2 (US 10,370,414) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
  • 1 fee due Apr 20, 2027
    The maintenance fee for Designed Ankyrin Repeat Proteins Binding to Platelet-Derived Growth Factor (US 9,163,070) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
  • 2 fees due Jun 5 to 29, 2027 · next Jun 5
  • 2 fees due Sep 15 to 22, 2027 · next Sep 15
  • 1 fee due Nov 12, 2027
    The maintenance fee for Modified Binding Proteins Inhibiting the VEGF-A Receptor Interaction (US 10,646,542) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,710,187Modified Binding Proteins Inhibiting the VEGF-A Receptor Interaction
In force
 · High confidence
In forceHigh confidence
US 9,289,466Modified Binding Proteins Inhibiting the VEGF-A Receptor Interaction
In force
 · High confidence
In forceHigh confidence
US 9,849,158Modified Binding Proteins Inhibiting the VEGF-A Receptor Interaction
In force
 · High confidence
In forceHigh confidence
US 10,646,542Modified Binding Proteins Inhibiting the VEGF-A Receptor Interaction
In force
 · High confidence
In forceHigh confidence
US 8,901,076Binding Proteins Inhibiting the VEGF-A Receptor Interaction
In force
 · High confidence
In forceHigh confidence
US 9,221,892Improved Capping Modules for Designed Ankyrin Repeat Proteins
In force
 · High confidence
In forceHigh confidence
US 9,284,361Designed Repeat Proteins Binding to Serum Albumin
In force
 · High confidence
In forceHigh confidence
US 9,717,802Improved Capping Modules for Designed Ankyrin Repeat Proteins
In force
 · Medium confidence
In forceMedium confidence
US 9,775,912Designed Repeat Proteins Binding to Serum Albumin
In force
 · Low confidence
In forceLow confidence
US 10,322,190Capping Modules for Designed Ankyrin Repeat Proteins
In force
 · Low confidence
In forceLow confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
Also on record, not counted in the 22: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 11 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited